Sarepta Therapeutics Inc (SRPT)

Inventory turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cost of revenue	US$ in thousands	319,099	150,343	139,989	97,049	63,382
Inventory	US$ in thousands	749,960	322,859	203,968	186,212	231,961
Inventory turnover		0.43	0.47	0.69	0.52	0.27

December 31, 2024 calculation

Inventory turnover = Cost of revenue ÷ Inventory
= $319,099K ÷ $749,960K
= 0.43

The inventory turnover ratio for Sarepta Therapeutics Inc has shown fluctuations over the past five years. In 2020, the ratio was relatively low at 0.27, indicating that the company took approximately 1.3 years to sell its entire inventory. However, this ratio improved in 2021 to 0.52, suggesting that the company was able to turn over its inventory more quickly, taking around 0.7 years to sell its inventory.

Subsequently, in 2022, the inventory turnover ratio further increased to 0.69, indicating an even better performance in managing its inventory, with the company taking approximately 0.6 years to sell its inventory. However, there was a slight decline in 2023, with the ratio dropping to 0.47, suggesting that it took around 0.9 years to sell its inventory during that period.

In the most recent year, 2024, the inventory turnover ratio decreased to 0.43, showing a slight decrease in the efficiency of inventory management, with the company taking approximately 0.8 years to sell its inventory. Overall, while there have been fluctuations in Sarepta Therapeutics Inc's inventory turnover ratio over the years, the company has generally shown an improvement in managing its inventory efficiently.